Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysisResearch in context

Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysisResearch in context

Summary: Background: The COVID-19 global pandemic placed unprecedented pressure on cancer services, requiring new interim Systemic Anti-Cancer Treatments (SACT) options to mitigate risks to patients and maintain cancer services. In this study we analyse interim COVID-19 SACT therapy options recomme...

Full description

Bibliographic Details
Main Authors: Mark P. Lythgoe, Alica-Joana Emhardt, Huseyin Naci, Jonathan Krell, Richard Sullivan, Ajay Aggarwal
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:The Lancet Regional Health. Europe
Subjects:
Cancer
COVID-19
NICE
Immunosuppression
Immunotherapy
Immune checkpoint inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776224002291

Internet

http://www.sciencedirect.com/science/article/pii/S2666776224002291

Similar Items